GFM
IDXX icon

GF Fund Management’s Idexx Laboratories IDXX Stock Holding History

GF Fund Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.54M Sell
18,120
-411
-2% -$231K 0.11% 105
2026
Q1 		$10.4M Sell
18,531
-479
-3% -$307K 0.17% 87
2025
Q4 		$12.9M Buy
19,010
+786
+4% +$535K 0.22% 75
2025
Q3 		$11.6M Buy
18,224
+130
+0.7% +$78.9K 0.21% 88
2025
Q2 		$9.7M Buy
18,094
+222
+1% +$106K 0.2% 96
2025
Q1 		$7.51M Buy
17,872
+261
+1% +$113K 0.18% 108
2024
Q4 		$7.28M Buy
+17,611
New +$7.72M 0.16% 110

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GF Fund Management's IDXX Position: Q2 2026 in Review

GF Fund Management reduced its Idexx Laboratories (IDXX) stake by 2.2% in Q2 2026, selling an estimated $231K and leaving 18,120 shares worth $9.54M. The position accounts for 0.11% of the portfolio, ranked #105.

GF Fund Management first reported a position in IDXX in Q4 2024 and has held it in 7 quarters since. The position peaked at $12.9M in Q4 2025. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • GF Fund Management held 18,120 shares of Idexx Laboratories worth $9.54M as of Q2 2026.
  • GF Fund Management sold 411 Idexx Laboratories shares in Q2 2026, an estimated $231K.
  • Idexx Laboratories made up 0.11% of GF Fund Management's portfolio in Q2 2026, its #105 holding.
  • GF Fund Management first reported a position in Idexx Laboratories in Q4 2024 and has held it in 7 quarters since.
  • GF Fund Management's Idexx Laboratories position peaked at $12.9M in Q4 2025.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.